{"id":"https://openalex.org/W2009786335","doi":"https://doi.org/10.1038/bjc.2012.369","title":"Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials","display_name":"Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials","publication_year":2012,"publication_date":"2012-08-21","ids":{"openalex":"https://openalex.org/W2009786335","doi":"https://doi.org/10.1038/bjc.2012.369","mag":"2009786335","pmid":"https://pubmed.ncbi.nlm.nih.gov/22910317","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3461163"},"language":"en","primary_location":{"id":"doi:10.1038/bjc.2012.369","doi":"https://doi.org/10.1038/bjc.2012.369","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2012.369","pdf_url":"https://www.nature.com/articles/bjc2012369.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/bjc2012369.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026202643","display_name":"Alexandra N. Giatromanolaki","orcid":"https://orcid.org/0000-0003-3706-8845","observed_orcids":["https://orcid.org/0000-0003-3706-8845"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"A Giatromanolaki","raw_affiliation_strings":["Departments of Pathology, and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis 68100, Greece","Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology, and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis 68100, Greece","institution_ids":["https://openalex.org/I147962203"]},{"raw_affiliation_string":"Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece","institution_ids":["https://openalex.org/I147962203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026228151","display_name":"Michael Ioannis Koukourakis","orcid":"https://orcid.org/0000-0002-2324-699X","observed_orcids":["https://orcid.org/0000-0002-2324-699X"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"M I Koukourakis","raw_affiliation_strings":["Departments of Pathology, and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, 68100, Greece","Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology, and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, 68100, Greece","institution_ids":["https://openalex.org/I147962203"]},{"raw_affiliation_string":"Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece","institution_ids":["https://openalex.org/I147962203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033275045","display_name":"Efthimios Sivridis","orcid":"https://orcid.org/0000-0002-2802-1386","observed_orcids":["https://orcid.org/0000-0002-2802-1386"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"E Sivridis","raw_affiliation_strings":["Departments of Pathology, and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, 68100, Greece","Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology, and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, 68100, Greece","institution_ids":["https://openalex.org/I147962203"]},{"raw_affiliation_string":"Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece","institution_ids":["https://openalex.org/I147962203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108427843","display_name":"Kevin C. Gatter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K C Gatter","raw_affiliation_strings":["Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, Cancer Research UK, Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, OX3 9DS, UK","Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, Cancer Research UK, Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, Cancer Research UK, Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, OX3 9DS, UK","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I2802742124","https://openalex.org/I4210110594"]},{"raw_affiliation_string":"Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, Cancer Research UK, Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I2802742124","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039743409","display_name":"Tanja Trarbach","orcid":"https://orcid.org/0000-0002-1275-4040","observed_orcids":["https://orcid.org/0000-0002-1275-4040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Trarbach","raw_affiliation_strings":["University of Essen, West German Cancer Center, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019710731","display_name":"Gunnar Folprecht","orcid":"https://orcid.org/0000-0002-9321-9911","observed_orcids":["https://orcid.org/0000-0002-9321-9911"]},"institutions":[{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"G Folprecht","raw_affiliation_strings":["University Hospital Dresden, Dresden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082586117","display_name":"M. Shi","orcid":"https://orcid.org/0009-0001-3353-328X","observed_orcids":["https://orcid.org/0009-0001-3353-328X"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M M Shi","raw_affiliation_strings":["Novartis Pharmaceuticals Co, East Hanover, NJ, USA","Novartis Pharmaceuticals Co., East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Co, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062128184","display_name":"David Lebwohl","orcid":"https://orcid.org/0000-0002-4578-1977","observed_orcids":["https://orcid.org/0000-0002-4578-1977"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Lebwohl","raw_affiliation_strings":["Novartis Pharmaceuticals Co, East Hanover, NJ, USA","Novartis Pharmaceuticals Co., East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Co, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108523526","display_name":"Tarja Jalava","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"T Jalava","raw_affiliation_strings":["Bayer Schering Pharma Oy, Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068520667","display_name":"Dirk Laurent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D Laurent","raw_affiliation_strings":["Bayer Healthcare Pharmaceuticals, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":null,"display_name":"G Meinhardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Meinhardt","raw_affiliation_strings":["Bayer Healthcare Pharmaceuticals, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, NJ, USA","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079633934","display_name":"Adrian Llewellyn Harris","orcid":"https://orcid.org/0000-0003-1376-8409","observed_orcids":["https://orcid.org/0000-0003-1376-8409","https://orcid.org/0000-0002-5222-4765"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A L Harris","raw_affiliation_strings":["Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, Cancer Research UK, Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, OX3 9DS, UK","Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, Cancer Research UK, Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, Cancer Research UK, Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, OX3 9DS, UK","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I2802742124","https://openalex.org/I4210110594"]},{"raw_affiliation_string":"Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, Cancer Research UK, Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I2802742124","https://openalex.org/I4210110594"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5026228151"],"corresponding_institution_ids":["https://openalex.org/I147962203"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":0.7167,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.63366714,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"107","issue":"7","first_page":"1044","last_page":"1050"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.010900000110268593,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vessel-density","display_name":"vessel density","score":0.7760000228881836},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/vatalanib","display_name":"vatalanib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ptk787-zk222584","display_name":"PTK787/ZK222584","score":0.9309999942779541},{"id":"https://openalex.org/keywords/vegfr2-phosphorylation","display_name":"VEGFR2 phosphorylation","score":0.7789999842643738},{"id":"https://openalex.org/keywords/kdr","display_name":"KDR","score":0.718999981880188},{"id":"https://openalex.org/keywords/cd31","display_name":"CD31","score":0.8230000138282776},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8980000019073486},{"id":"https://openalex.org/keywords/serum-lactate-dehydrogenase","display_name":"serum lactate dehydrogenase","score":0.652999997138977},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8270000219345093},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9850000143051147},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.550000011920929},{"id":"https://openalex.org/keywords/patient-stratification","display_name":"patient stratification","score":0.7590000033378601},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.865081787109375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7072155475616455},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6987150311470032},{"id":"https://openalex.org/C2778939058","wikidata":"https://www.wikidata.org/wiki/Q4046167","display_name":"CD31","level":3,"score":0.6548494696617126},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6097257137298584},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6000013947486877},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5840040445327759},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5513477325439453},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4514261782169342},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4309364855289459},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41656529903411865},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.412699818611145},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33248668909072876},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.27786320447921753},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.10037833452224731},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019408","descriptor_name":"Platelet Endothelial Cell Adhesion Molecule-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D040301","descriptor_name":"Vascular Endothelial Growth Factor Receptor-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/bjc.2012.369","doi":"https://doi.org/10.1038/bjc.2012.369","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2012.369","pdf_url":"https://www.nature.com/articles/bjc2012369.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2771004","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3461163","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:22910317","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22910317","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pubmedcentral.nih.gov:3461163","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3461163/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1038/bjc.2012.369","doi":"https://doi.org/10.1038/bjc.2012.369","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2012.369","pdf_url":"https://www.nature.com/articles/bjc2012369.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1425849753","display_name":null,"funder_award_id":"11359","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G7499079676","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0611-10163","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2009786335.pdf","grobid_xml":"https://content.openalex.org/works/W2009786335.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W119001892","https://openalex.org/W1592202036","https://openalex.org/W1596286692","https://openalex.org/W1868766650","https://openalex.org/W1980549837","https://openalex.org/W1985712533","https://openalex.org/W1988978946","https://openalex.org/W1993040477","https://openalex.org/W2006202974","https://openalex.org/W2012902489","https://openalex.org/W2035127867","https://openalex.org/W2042049016","https://openalex.org/W2083135484","https://openalex.org/W2085214163","https://openalex.org/W2112759697","https://openalex.org/W2113135799","https://openalex.org/W2116398398","https://openalex.org/W2130596822","https://openalex.org/W2139874845","https://openalex.org/W2144893998","https://openalex.org/W2147325805","https://openalex.org/W2148218538","https://openalex.org/W2152004983","https://openalex.org/W2157019123","https://openalex.org/W2211228914","https://openalex.org/W2398137194"],"related_works":["https://openalex.org/W1979877809","https://openalex.org/W1972543827","https://openalex.org/W2083135484","https://openalex.org/W1964238095","https://openalex.org/W2152004983","https://openalex.org/W2363118804","https://openalex.org/W2116398398","https://openalex.org/W2092682349","https://openalex.org/W2072169086","https://openalex.org/W2386292606"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pharmacological":[1],"inhibitors":[2],"of":[3,26,30,43,59,83,90,116,202,211,236,247],"vascular":[4,60],"endothelial":[5,94],"growth":[6],"factor":[7],"(VEGF)":[8],"receptors,":[9],"like":[10],"vatalanib,":[11],"have":[12],"been":[13],"tested":[14],"in":[15,35,40,63,66,122,152,170,187,214,229],"randomised":[16,215],"trials":[17,216],"(CONFIRM":[18],"(Colorectal":[19],"Oral":[20],"Novel":[21],"therapy":[22,103],"For":[23],"the":[24,51,56,67,81,84,123,203,209,230,234,241,245],"Inhibition":[25],"Angiogenesis":[27],"and":[28,33,89,104,108,225],"Retarding":[29],"Metastases)":[31],"1":[32],"2)":[34],"colorectal":[36],"cancer":[37],"showing":[38],"activity":[39],"a":[41],"subgroup":[42],"patients":[44,64,75,171,188,212],"with":[45,78,100,105,119,154,172,178,189,217],"high":[46,134,155,173,190],"serum":[47],"LDH":[48],"expression.":[49],"In":[50],"current":[52],"study,":[53],"we":[54],"assessed":[55],"predictive":[57],"role":[58],"density":[61,206],"(VD)":[62],"treated":[65,177],"above":[68],"trials.":[69],"METHODS:":[70],"Paraffin-embedded":[71],"materials":[72],"from":[73,146],"141":[74],"were":[76],"analysed":[77],"immunohistochemistry":[79],"for":[80,233],"expression":[82],"CD31":[85],"(pan-endothelial":[86],"cell":[87],"marker)":[88],"phosphorylated":[91],"pVEGFR2/KDR":[92],"on":[93],"cells.":[95],"The":[96,143],"VD":[97,118,135,156,175,192],"was":[98,126,159,168,184,196],"correlated":[99],"response":[101,121],"to":[102,149,161],"progression-free":[106],"(PFS)":[107],"overall":[109],"survival":[110,195],"(OS).":[111],"RESULTS:":[112],"A":[113,164,181],"significant":[114],"association":[115],"pVEGFR2/KDR+":[117,174],"poor":[120],"placebo":[124],"group":[125],"noted":[127,169,186],"(response":[128],"rates":[129],"(RRs)":[130],"15%":[131],"(3/20)":[132,148],"when":[133,139,157,176],"vs":[136],"52%":[137],"(26/50)":[138],"low":[140],"VD;":[141],"P=0.006).":[142],"RR":[144],"increased":[145],"15":[147],"50%":[150],"(11/22)":[151],"tumours":[153],"vatalanib":[158,179],"added":[160],"chemotherapy":[162],"(P=0.02).":[163],"significantly":[165],"improved":[166,198],"PFS":[167],"(P=0.002).":[180],"similar":[182],"effect":[183],"also":[185],"CD31+":[191],"(P=0.07).":[193,199],"Overall":[194],"marginally":[197],"CONCLUSION:":[200],"Assessment":[201],"activated":[204],"vessel":[205],"may":[207],"allow":[208],"stratification":[210],"recruited":[213],"VEGFR-targeting":[218],"anti-angiogenic":[219],"agents,":[220],"unmasking":[221],"their":[222,227],"therapeutic":[223],"potential":[224],"enabling":[226],"introduction":[228],"clinical":[231],"practice":[232],"benefit":[235],"specific":[237],"patient":[238],"subgroups,":[239],"at":[240],"same":[242],"time":[243],"reducing":[244],"cost":[246],"therapy.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}